Bioceres Crop Solutions (NASDAQ:BIOX) Announces Earnings Results

Bioceres Crop Solutions (NASDAQ:BIOX) released its quarterly earnings results on Wednesday. The company reported ($0.16) EPS for the quarter, missing analysts’ consensus estimates of $0.02 by ($0.18), Zacks reports. Bioceres Crop Solutions had a negative return on equity of 41.35% and a negative net margin of 94.76%.

Bioceres Crop Solutions Price Performance

BIOX traded up $0.02 during midday trading on Wednesday, hitting $0.23. The stock had a trading volume of 93,483 shares, compared to its average volume of 470,421. Bioceres Crop Solutions has a 1 year low of $0.19 and a 1 year high of $2.03. The company has a debt-to-equity ratio of 1.76, a quick ratio of 0.62 and a current ratio of 0.80. The business has a fifty day moving average of $0.32 and a 200 day moving average of $0.44. The company has a market cap of $14.85 million, a P/E ratio of -0.06 and a beta of 0.54.

Wall Street Analyst Weigh In

Separately, Weiss Ratings restated a “sell (d-)” rating on shares of Bioceres Crop Solutions in a research report on Friday, October 9th. One research analyst has rated the stock with a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Reduce” and a consensus target price of $2.00.

Bioceres Crop Solutions Company Profile

Bioceres Crop Solutions Corp. is an Argentina-based agricultural biotechnology company focused on developing technologies that improve crop productivity, resilience and sustainability. The company serves farmers and agricultural businesses through products designed to support crop establishment, nutrition, protection and performance under challenging environmental conditions. Its portfolio includes the HB4 biotechnology platform, which is used in drought-tolerant wheat and soybean varieties, as well as biological seed treatments, microbial inoculants, biofertilizers, biostimulants and biological crop-protection products.